XERS - Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

2024-03-06 12:43:15 ET

Xeris Biopharma Holdings Inc. (XERS)

Q4 2023 Earnings Conference Call

March 6, 2024 8:30 am ET

Company Participants

Paul Edick - Chairman, Chief Executive Officer

Steve Pieper - Chief Financial Officer

Allison Wey - Senior Vice President, Investor Relations

Conference Call Participants

Oren Livnat - HC Wainwright

Glen Santangelo - Jefferies

Chase Knickerbocker - Craig Hallum

Roanna Ruiz - Leerink Partners

David Amsellem - Piper Sandler

Presentation

Operator

Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results conference call and webcast. My name is Emily and I’ll be coordinating your call today.

After the presentation, there will be the opportunity for you to ask any questions, which you can do by pressing star followed by the number one on your telephone keypad.

I’ll now turn the call over to Allison Wey, Senior Vice President of Investor Relations. Please go ahead.

Allison Wey

Thank you Emily. Good morning and welcome to Xeris Biopharma’s fourth quarter and full year 2023 financial results and conference call.

This morning we issued two press releases, one on the company’s financial results and the other on refinancing our debt facility with Hayfin Capital. Both can be found on our website....

For further details see: